Results 261 to 270 of about 23,782 (335)

Photodynamic Treatment of 206 Thin (≤ 1 mm) Basal Cell Carcinomas Using a Biphasic Activation Protocol: The Outcomes Over a 7‐Year Period and the Rationale Behind the Treatment

open access: yesJEADV Clinical Practice, EarlyView.
Photodynamic treatment using a 2‐phased activation protocol consisting of red light followed immediately by IPL delivered with mechanical pressure to squeeze out blood was highly successful in a group of 206 thin BCCs ( ≤ 1 mm maximum thickness). Optical coherence tomography (OCT) was used for triage and to monitor outcomes.
Robert Stephens   +4 more
wiley   +1 more source

A Retrospective Analysis Into the Effect of Punch Grafts in Patients With Chronic Ulcers of the Lower Leg

open access: yesJEADV Clinical Practice, EarlyView.
Punch grafting was retrospectively evaluated in patients with chronic lower leg ulcers treated at Erasmus MC between 2018 and 2023. Median pain scores significantly decreased after 6 weeks. Opioid use declined and 30% of patients no longer required analgesics. Complete wound closure was achieved in 7% of cases.
M. van Zanten   +4 more
wiley   +1 more source

THERAPUTIC ALTERNATIVES FOR PHANTOM LIMB PAIN FOLLOWING SURGERY

open access: hybrid, 2018
Alla Ryazankina   +4 more
openalex   +2 more sources

Painful Phantom Upper Limb [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1938
openaire   +3 more sources

Identifying discriminant factors between phantom limb pain, residual limb pain, and both in people with lower limb amputations: a cross-sectional study. [PDF]

open access: yesInt J Rehabil Res
Pournajaf S   +7 more
europepmc   +1 more source

Abstract: Targeted Muscle Reinnervation Successfully Treats Neuroma Pain and Phantoms in Major Limb Amputees: A Randomized Clinical Trial

open access: gold, 2018
Gregory A. Dumanian   +11 more
openalex   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy